Luis Gomez, MD
Vascular Surgery · Mishawaka, INNPI 1538570460
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $39,505 of the $52,050 with a category attached, or 75.9%. Endologix LLC accounts for 89.5% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $29,273, more than ten times the $304 reported in 2021. Among vascular surgery clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $335.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$47K
- Penumbra, Inc.$3K
- W. L. Gore & Associates, Inc.$577
- Cardiovascular Systems Inc.$304
- Terumo Medical Corporation$285
- Lemaitre Vascular, Inc.$243
- plus $1K from 23 others
What the payments were for
- Consulting fees$39,50576%
- Travel & lodging$4,3008%
- Food & beverage$8,01715%
- Education$2290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 80 | $46,585 |
| Penumbra, Inc. | 13 | $2,729 |
| W. L. Gore & Associates, Inc. | 5 | $577 |
| Cardiovascular Systems Inc. | 11 | $304 |
| Terumo Medical Corporation | 2 | $285 |
| Lemaitre Vascular, Inc. | 5 | $243 |
| Johnson & Johnson(2 entities) | 7 | $225 |
| Reflow Medical Inc | 1 | $141 |
| Shockwave Medical, Inc | 5 | $140 |
| Medical Device Business Services, Inc. | 1 | $137 |
| Boston Scientific | 1 | $136 |
| Bolton Medical Inc | 2 | $73 |
| Novartis | 3 | $71 |
| Medtronic | 2 | $57 |
| Smith+Nephew | 2 | $48 |
| Kerecis Limited | 1 | $37 |
| Organogenesis Inc. | 1 | $28 |
| Mozarc Medical US LLC | 1 | $26 |
| Surmodics, Inc. | 1 | $25 |
| Abbott | 1 | $24 |
| Baxter Healthcare | 1 | $23 |
| Pfizer | 1 | $23 |
| Cook Medical LLC | 1 | $19 |
| Convatec Inc. | 1 | $18 |
| Abiomed | 1 | $17 |
| TELA Bio, Inc. | 2 | $17 |
| Solventum Corporation | 1 | $15 |
| Clinical Technology, Inc | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alto Abdominal Stent Graft System$25,211
- Torus Stent Graft System$15,717
- ENDOCROSS Device$15,717
- AFX2 Bifurcated Endograft System$15,189
- Indigo System$2,528
- GORE EXCLUDER AAA Endoprosthesis$357
- ANGIO-SEAL$176
- STRATAFIX$137
- WATCHMAN Access System$136
- Diamondback Peripheral$130
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$113
- Azur CX Detachable$109
- RESTOREFLOW$103
How this compares
$52,050 in reported general payments places this provider in the 90th percentile of 71 vascular surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $20,257 |
| ClopidogrelClopidogrel Bisulfate | 351 | $3,300 |
| Atorvastatin Calcium | 246 | $1,773 |
| Rosuvastatin Calcium | 49 | $457 |
| Pregabalin | 13 | $338 |
| Cilostazol | 12 | $254 |
| Gabapentin | 26 | $198 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 24 | $122 |
| Prednisone | 17 | $24 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $23 | $20,25723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 71 vascular surgery providers in Indiana.
Other vascular surgery in Mishawaka
- Ziad FayadMishawaka$12K
- Michael ShaoFort Wayne$155K
- Sajjad HussainIndianapolis$109K
- Ricardo VasquezBloomington$82K
- Andres FajardoIndianapolis$58K
- Angela MartinEvansville$54K
- Matthew LangenbergEvansville$36K
- Brandon DowningIndianapolis$33K
- Deepak GuttikondaIndianapolis$33K
- Jeffrey WeinbergerIndianapolis$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.